Terms: = Colorectal cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Staging
10 results:
1. Determination of a CD4+CD25+ foxp3+T cells subset in Egyptian colorectal cancer Patients.
Elsheshtawy NM; Saad M; El-Ghamrini YM; Ziada KW
Egypt J Immunol; 2021 Jul; 28(3):145-156. PubMed ID: 34453786
[TBL] [Abstract] [Full Text] [Related]
2. A study of the immune infiltrate and patient outcomes in esophageal cancer.
Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J
Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666
[TBL] [Abstract] [Full Text] [Related]
3. [Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer].
Han ZH; Chen JJ; Feng N; Niu PF; Song C; Gao ZY; Gao QK; Ji DB; Wang WB; Lei FM; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):966-971. PubMed ID: 31630495
[No Abstract] [Full Text] [Related]
4. Combined Low Densities of foxp3
Cavalleri T; Bianchi P; Basso G; Celesti G; Grizzi F; Bossi P; Greco L; Pitrone C; Valtorta E; Mauri G; Truini M; Dall'Olio FG; Brandi G; Sartore-Bianchi A; Ricciardiello L; Torri V; Rimassa L; Siena S; Mantovani A; Malesci A; Laghi L;
Cancer Immunol Res; 2019 May; 7(5):751-758. PubMed ID: 30804005
[TBL] [Abstract] [Full Text] [Related]
5. Inclusion of BLIMP-1
Ward-Hartstonge KA; McCall JL; McCulloch TR; Kamps AK; Girardin A; Cretney E; Munro FM; Kemp RA
Cancer Immunol Immunother; 2017 Apr; 66(4):515-522. PubMed ID: 28116480
[TBL] [Abstract] [Full Text] [Related]
6. Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer.
Yan X; Jiao SC; Zhang GQ; Guan Y; Wang JL
Cancer Gene Ther; 2017 Feb; 24(2):57-63. PubMed ID: 28084319
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Utility of Immunoprofiling in Colon cancer: Results from a Prospective, Multicenter Nodal Ultrastaging Trial.
Flaherty DC; Lavotshkin S; Jalas JR; Torisu-Itakura H; Kirchoff DD; Sim MS; Lee DJ; Bilchik AJ
J Am Coll Surg; 2016 Jul; 223(1):134-40. PubMed ID: 27282965
[TBL] [Abstract] [Full Text] [Related]
8. Combining foxp3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.
Abd Al Samid M; Chaudhary B; Khaled YS; Ammori BJ; Elkord E
Oncotarget; 2016 Mar; 7(12):14083-94. PubMed ID: 26885615
[TBL] [Abstract] [Full Text] [Related]
9. Immunoprofiling for prognostic assessment of colon cancer: a novel complement to ultrastaging.
Lavotshkin S; Jalas JR; Torisu-Itakura H; Ozao-Choy J; Lee JH; Sim MS; Stojadinovic A; Wainberg Z; Bifulco CB; Fox BA; Bilchik AJ
J Gastrointest Surg; 2015 Jun; 19(6):999-1006. PubMed ID: 25808375
[TBL] [Abstract] [Full Text] [Related]
10. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
Zlobec I; Lugli A
World J Gastroenterol; 2009 Dec; 15(47):5898-906. PubMed ID: 20014453
[TBL] [Abstract] [Full Text] [Related]
